AINDEX
Markets

Abbott Laboratories (ABT)

ABTNYSEBiotechnology: Pharmaceutical Preparations

$110.31

+0.3775 (+0.34%) today

Closed, Nov 9, 4:03 PM ET

+0.34% 1D
Market cap
$191.43bn
P/E
20.5
EPS, last 4 quarters
$5.38
Dividend yield
–
Day range
–
52-week range
$81.97 to $132.03
Average volume
5.45m
Previous close
$109.93

Analysts

17 covering

Buy16 buy, 1 hold, 0 sell

Targets a year out average $122.56, +11.1% from here

$115.00now $110.31$135.00

Earnings

next estimate $1.64

Next report

Dec 2025

0.0%

Mar 2026

+0.9%

Jun 2026

+2.3%

Sep 2026

-0.7%

estimate reported, and the surprise

Financials

QuarterDec 2025Mar 2026Jun 2026Sep 2026
Revenue$11.46bn$11.16bn$12.59bn$13.01bn
Gross profit$6.54bn$6.27bn$7.27bn$7.38bn
Operating income$2.25bn$1.34bn$1.69bn$1.36bn
Net income$1.78bn$1.08bn$928.00m$920.00m

Last four quarters: revenue $48.23bn, margin 9.8%, free cash flow $6.76bn

News

8 latest

The company

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 122,000 colleagues serve people in more than 160 countries.

Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Exchange
NYSE
Region
North America
Website
abbott.com

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.